Creative Planning’s NanoViricides NNVC Stock Holding History

Creative Planning’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	+86,761	New	+$119K	﹤0.01%	4013
2017 Q3	–	Sell	-397	Closed	-$11K	–	3079
2017 Q2	$11K	Hold	397	–	–	﹤0.01%	3577
2017 Q1	$9K	Sell	397 -429	-52%	-$10K	﹤0.01%	3654
2016 Q4	$18K	Buy	826 +429	+108%	+$11.4K	﹤0.01%	3147
2016 Q3	$13K	Hold	397	–	–	﹤0.01%	3329
2016 Q2	$13K	Hold	397	–	–	﹤0.01%	3082
2016 Q1	$17K	Hold	397	–	–	﹤0.01%	2870
2015 Q4	$9K	Hold	397	–	–	﹤0.01%	3365
2015 Q3	$9K	Buy	+397	New	+$10.5K	﹤0.01%	3271
2015 Q2	–	Sell	-114	Closed	-$5K	–	2354
2015 Q1	$5K	Hold	114	–	–	﹤0.01%	3546
2014 Q4	$6K	Hold	114	–	–	﹤0.01%	3408
2014 Q3	$7K	Hold	114	–	–	﹤0.01%	3140
2014 Q2	$10K	Hold	114	–	–	﹤0.01%	2874
2014 Q1	$7K	Sell	114 -136	-54%	-$11.6K	﹤0.01%	2935
2013 Q4	$24K	Buy	+250	New	+$25.7K	﹤0.01%	2074

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Creative Planning's NNVC Position: Q2 2026 in Review

Creative Planning opened a new position in NanoViricides (NNVC) in Q2 2026: 86,761 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #4013 among its holdings. This is a return to the name: Creative Planning previously reported a position in NNVC as recently as Q2 2017.

Creative Planning first reported a position in NNVC in Q4 2013 and has held it in 15 quarters since. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Creative Planning held 86,761 shares of NanoViricides worth $120K as of Q2 2026.
NanoViricides was a new Creative Planning position in Q2 2026.
NanoViricides made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4013 holding.
Creative Planning first reported a position in NanoViricides in Q4 2013 and has held it in 15 quarters since.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.